Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Waiting too long to redeem credit card points can lead to lost rewards and missed opportunities. Learn how to maximize your benefits.
26,518 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A tech stock sell-off can create compelling buying opportunities. This guide shows how to load up with a single ETF, ...
Russia’s messaging clampdown tests decentralization in the real world, revealing a gap between ideal tech and user wi...
As markets shift in early 2026, dividend-growth stocks offer retirees predictable income. Here are four blue chips wi...
As markets wobble in 2026, retirees face hidden costs from withdrawal sequencing and tax drag that quietly erode life...
A new Northwestern Mutual study finds half of Americans fear their retirement savings won't last, with many taking no...
The AI race is intensifying, and investor nerves are on edge. This article breaks down what a potential 'checkmate' m...
Ethereum faces a potential leap in value as a long-term ZK-based upgrade gains traction. ConsenSys founder Joseph Lub...
Begin your week with a calm, informed glance at the markets. This monday reads roundup delivers 10 timely investing p...
Chipotle stock has surged about 17% in the last month as investors anticipate July earnings. This article breaks down...
Google brings music generation to Gemini signals a new AI-powered feature for crypto users and content creators. We t...
Investors are eyeing hydrogen leaders as Plug Power remains in the spotlight. This piece breaks down why plug power s...